Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 27, 2010
Comparative study of CYP1A1 induction by 3-methylcholanthrene in various human hepatic and epidermal cell typesC Delescluse, N Ledirac, G de Sousa, et al.Biochemical Pharmacology|February 28, 2001
Induction of cytochrome P450 1A1 gene expression, oxidative stress, and genotoxicity by carbaryl and thiabendazole in transfected human HepG2 and lymphoblastoid cellsC Delescluse, N Ledirac, R Li, et al.Journal of Toxicology and Environmental Health|January 1, 1996
Evaluation of the toxicological risk to humans of caulerpenyne using human hematopoietic progenitors, melanocytes, and keratinocytes in cultureD Parent-Massin, V Fournier, P Amade, et al.Carcinogenesis|January 1, 1982
Effect of phorbol esters on guniea pig skin in vivoM C Bourin, C Delescluse, G Fürstenberger, et al.Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1990
Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptorsJ Bailly, C Delescluse, J M Bernardon, et al.Toxicology and Applied Pharmacology|May 1, 1997
Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptorN Ledirac, C Delescluse, G de Sousa, et al.Molecular Pharmacology|October 1, 1991
Selective high affinity retinoic acid receptor alpha or beta-gamma ligandsC Delescluse, M T Cavey, B Martin, et al.Toxicology and Applied Pharmacology|May 9, 2000
Diflubenzuron, a benzoyl-urea insecticide, is a potent inhibitor of TCDD-induced CYP1A1 expression in HepG2 cellsN Ledirac, C Delescluse, P Lesca, et al.Biochemical and Biophysical Research Communications|July 31, 1992
Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gammaB A Bernard, J M Bernardon, C Delescluse, et al.Pageof 3